Komori
KYORIN Pharmaceutical (4569) · PolicyRestated

Application of the Consolidated Taxation System and Change in Quarterly Tax Expense Calculation

First written in FY2021-Q1. 6 of 8 entries say "Restated". Latest entry: FY2024-Q3.

8entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021-Q1 – FY2021-Q3RestatedFY2022-Q2 – FY2024-Q32020: 220202021: 320212022: 220222023: 020232024: 1
Same theme, other companies
Streamlining Tax Expense Calculations in Quarterly Financial ResultsA theme 98 companies write about · 0 as a headwind · 85 as a tailwind

79 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 98 companies compared. The sentences above are computed from all 98.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q3RestatedAnnual report

    「For tax expenses, we estimate on a reasonable basis the effective tax rate after applying tax-effect accounting to income before income taxes for the consolidated fiscal year that includes the consolidated accounting period for the third quarter under review, and calculate quarterly income taxes by multiplying income before income taxes for the quarter by that estimated effective tax rate.」

    The company continues to apply the method of calculating quarterly tax expenses using the estimated effective tax rate.
  2. FY2023-Q1RestatedAnnual report

    「Tax expenses are calculated by reasonably estimating the effective tax rate after applying tax-effect accounting to profit before income taxes for the consolidated fiscal year that includes the first quarter of the current fiscal year, and multiplying quarterly profit before income taxes or quarterly loss before income taxes by the estimated effective tax rate.」

    Following the transition from the consolidated taxation system to the group tax sharing system, the company continues to calculate quarterly tax expenses using the estimated effective tax rate.
  3. FY2022-Q3RestatedAnnual report

    「For tax expenses, we estimate on a reasonable basis the effective tax rate after applying tax-effect accounting to income before income taxes for the consolidated fiscal year that includes the consolidated accounting period for the third quarter under review, and calculate quarterly income taxes by multiplying income before income taxes for the quarter by that estimated effective tax rate.」

    The company continues to calculate quarterly tax expenses using the estimated effective tax rate method following adoption of the consolidated taxation system.
  4. FY2022-Q2RestatedAnnual report

    「Tax expense is calculated by reasonably estimating the effective tax rate, after applying tax-effect accounting, on pretax income for the consolidated fiscal year that includes the second quarter, and multiplying pretax quarterly income by the estimated effective tax rate.」

    The company continues to calculate quarterly tax expenses using the estimated effective tax rate method following adoption of the consolidated taxation system.
  5. FY2022-Q1ReframedAnnual report

    「Our company and its domestic consolidated subsidiaries, with respect to the transition to the group tax sharing system established under the Act Partially Amending the Income Tax Act and Other Acts (Act No. 8 of 2020), and the items for which the standalone taxation system was revised in connection with the transition to the group tax sharing system,」

    While continuing to use the estimated effective tax rate method for quarterly tax expenses, the company is applying the tax-effect accounting treatment associated with the transition from the consolidated taxation system to the group tax sharing system.
  6. FY2021-Q3RestatedAnnual report

    「Tax expenses had previously been calculated using the same method as for the annual financial statements. Following the adoption of the consolidated taxation system from the first quarter, we changed the method from the first quarter to estimate a reasonable effective tax rate after applying tax-effect accounting to pre-tax income for the consolidated fiscal year, and calculate pre-tax quarterly net income by multiplying it by the estimated effective tax rate, in order to respond to quarterly financial reporting more promptly and efficiently.」

    The change to the estimated effective tax rate method accompanying adoption of the consolidated taxation system continues to be applied.
  7. FY2021-Q2RestatedAnnual report

    「Tax expenses had previously been calculated using the same method as for the annual financial statements. Following the adoption of the consolidated taxation system from the first quarter, we changed the method from the first quarter to estimate a reasonable effective tax rate after applying tax-effect accounting to pre-tax income for the consolidated fiscal year, and calculate pre-tax quarterly net income by multiplying it by the estimated effective tax rate, in order to respond to quarterly financial reporting more promptly and efficiently.」

    The change to the estimated effective tax rate method accompanying adoption of the consolidated taxation system continues to be applied in the second quarter.
  8. FY2021-Q1First statedAnnual report

    「Previously, tax expense was calculated using the same method as for the annual financial statements. However, because the consolidated taxation system was applied from the beginning of the first quarter of the consolidated fiscal year, we changed the method to estimate a reasonable effective tax rate after applying tax-effect accounting to pretax profit for the consolidated fiscal year and calculate quarterly tax expense by multiplying pretax quarterly profit by that estimated effective tax rate.」

    Following adoption of the consolidated taxation system, the Group changed its quarterly tax expense calculation from the first quarter of FY2020 to use an estimated effective tax rate.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.